Item 7.01 Regulation FD Disclosure.

On September 8, 2021, members of management of Sensei Biotherapeutics, Inc. (the "Company") will be discussing an updated company overview presentation during virtual one-on-one investor meetings. A copy of this slide presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

In accordance with General Instruction B.2. of Form 8-K, the information in this Item 7.01 and Exhibit 99.1 hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any of the Company's filings under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any incorporation language in such a filing, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits



Exhibit
Number                                Exhibit Description

99.1           Company Presentation.

104          The cover page from Sensei Biotherapeutics, Inc.'s Form 8-K filed on
             September 8, 2021, formatted in Inline XBRL.




                                       2

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses